Eastern Hepatobiliary Surgery Hospital
In research, Eastern Hepatobiliary Surgery Hospital stands highest in Life Sciences (#2,706 of 7,800 worldwide), Medicine (#3,661 of 10,443 worldwide) and Health Sciences (#5,035 of 11,982 worldwide), 2022–2025. Relative to its size it is most specialised in Hepatology, Cancer Research and Oncology — Hepatology is 73.5× its share of world research.
- World rank, 2022–2025
- #5,693 of 28,054 · #7,844 all time
- Rank in China
- #1,220 of 3,058
- Research works
- 1.8k ▼ 10% vs 2013–17
- Citations
- 46k 26.3 per fractional work
- Top-10% rate
- 23.1% record average 16.5%
- Open access
- 44% world 28%
What is Eastern Hepatobiliary Surgery Hospital known for in research?
The fields where it stands highest, 2022–2025, ranked among every institution above the floor in each field.
| Field | World rank | Where that sits | Top-10% rate | Works | All time |
|---|---|---|---|---|---|
| Life SciencesDomain | #2,706 of 7,800 | 27.1% | 82 | #3251 | |
| MedicineField | #3,661 of 10,443 | 21.1% | 213 | #4202 | |
| Health SciencesDomain | #5,035 of 11,982 | 21.1% | 216 | #5662 | |
| Biochemistry, Genetics and Molecular BiologyField | #2,576 of 3,579 | 25.2% | 67 | #2727 |
Each strip is that field’s whole ranked pool, with the notch where Eastern Hepatobiliary Surgery Hospital sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).
Which of those standings moved
The same fields on both windows: where it stood over the whole record, and where it stands in 2022–2025. The distance is the story, and it is the one thing the two rank columns above cannot show.
- Life Sciences#3,251 #2,706
- Medicine#4,202 #3,661
- Health Sciences#5,662 #5,035
- Biochemistry, Genetics and Molecular Biology#2,727 #2,576
A dot further right is a better standing. Fields it was not ranked in over the whole record are left out.
What does Eastern Hepatobiliary Surgery Hospital specialise in?
Where its research is concentrated relative to its size: Hepatology takes 73.5× the share of its output that it takes of world research.
- HepatologySubfield · 45.5 works73×
- Cancer ResearchSubfield · 21.4 works15×
- OncologySubfield · 32.7 works9.1×
- SurgerySubfield · 45.0 works6.0×
- Pulmonary and Respiratory MedicineSubfield · 29.5 works6.0×
- Biochemistry, Genetics and Molecular BiologyField · 67.2 works3.9×
- Molecular BiologySubfield · 37.6 works3.9×
Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 3.9×. Every wedge is a field page.
- Biochemistry, Genetics and Molecular Biology 3.9×
- Medicine 3.5×
- Immunology and Microbiology 2.9×
- Pharmacology, Toxicology and Pharmaceutics 1.5×
- Nursing 0.9×
- Neuroscience 0.6×
- Chemistry 0.5×
- Materials Science 0.4×
- Veterinary 0.3×
- Decision Sciences 0.2×
- Mathematics 0.2×
- Dentistry 0.2×
- Engineering 0.2×
- Health Professions 0.1×
- Psychology 0.1×
- Energy 0.1×
- Physics and Astronomy 0.1×
- Computer Science 0.1×
- Economics, Econometrics and Finance 0.1×
- Agricultural and Biological Sciences 0.1×
- Environmental Science 0.1×
- Arts and Humanities 0.0×
- Business, Management and Accounting 0.0×
- Social Sciences 0.0×
Which keywords describe research at Eastern Hepatobiliary Surgery Hospital?
By fractional works in 2022–2025, weighted toward what it does more of than the world: Hepatocellular Carcinoma, Cancer, Treatment, Clinical Practice Guidelines, Diagnosis, Management, Cholangiocarcinoma and Tumor Microenvironment.
- Epigenetic Regulation
- GPX4
- ERCP
- Lipid Peroxidation
- NASH
- Neoadjuvant Therapy
- Cell Death
- Metabolic Syndrome
- Gene Expression
- Chemotherapy
- Oxidative Stress
- Intrahepatic Cholangiocarcinoma
- Therapeutic Strategies
- Surgical Management
- Radiofrequency Ablation
- Tumor Microenvironment
- Cholangiocarcinoma
- Diagnosis
- Epidemiology
- Cancer
- Hepatocellular Carcinoma
- Treatment
- Clinical Practice Guidelines
- Management
- Survival
- Liver Cancer
- Prognostic Factors
- Molecular Pathology
- Biliary Tract Cancer
- Inflammation
- Immunotherapy
- Metastasis
- Cancer Progression
- Insulin Resistance
- Hepatic Steatosis
- NAFLD
- Angiogenesis
- Cholecystitis
- Ferroptosis
- Liver Transplantation
Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Hepatocellular Carcinoma47▲ 70×3 topics
- Cancer40▲ 9.4×42 topics
- Treatment39▲ 10×17 topics
- Epidemiology39▲ 3.0×51 topics
- Clinical Practice Guidelines38▲ 22×11 topics
- Diagnosis38▲ 13×16 topics
- Management38▲ 15×12 topics
- Cholangiocarcinoma36▲ 141×2 topics
- Survival34▲ 80×3 topics
- Tumor Microenvironment34▲ 24×8 topics
- Liver Cancer34▲ 192×1 topic
- Radiofrequency Ablation34▲ 101×1 topic
- Prognostic Factors30▲ 21×8 topics
- Surgical Management29▲ 22×14 topics
- Molecular Pathology27▲ 78×2 topics
- Therapeutic Strategies27▲ 86×2 topics
- Biliary Tract Cancer26▲ 222×1 topic
- Intrahepatic Cholangiocarcinoma26▲ 222×1 topic
- Inflammation23▲ 3.5×63 topics
- Oxidative Stress18▲ 3.5×34 topics
- Immunotherapy18▲ 7.8×14 topics
- Chemotherapy16▲ 7.3×21 topics
- Metastasis16▲ 15×12 topics
- Gene Expression16▲ 8.1×9 topics
- Cancer Progression14▲ 25×8 topics
- Metabolic Syndrome12▲ 4.7×16 topics
- Insulin Resistance11▲ 7.7×7 topics
- Cell Death11▲ 15×6 topics
- Hepatic Steatosis10▲ 20×2 topics
- Neoadjuvant Therapy10▲ 13×5 topics
- NAFLD10▲ 26×1 topic
- NASH10▲ 26×1 topic
- Angiogenesis10▲ 9.1×13 topics
- Lipid Peroxidation9▲ 28×2 topics
- Cholecystitis9▲ 69×1 topic
- ERCP9▲ 69×1 topic
- Ferroptosis9▲ 38×1 topic
- GPX49▲ 38×1 topic
- Liver Transplantation9▲ 24×4 topics
- Epigenetic Regulation8▲ 12×3 topics
Which research topics does Eastern Hepatobiliary Surgery Hospital publish most on?
By volume in 2022–2025: Hepatocellular Carcinoma Treatment and Prognosis, Cholangiocarcinoma and Gallbladder Cancer Studies, Liver Disease Diagnosis and Treatment and Gallbladder and Bile Duct Disorders.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Hepatocellular Carcinoma Treatment and Prognosis Hepatology 34 works
- 2 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 26 works
- 3 Liver Disease Diagnosis and Treatment Epidemiology 10 works
- 4 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 9 works
- 5 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 9 works
- 6 Pancreatic and Hepatic Oncology Research Oncology 8 works
- 7 RNA modifications and cancer Molecular Biology 7 works
- 8 Cancer Mechanisms and Therapy Pathology and Forensic Medicine 7 works
- 9 Cancer-related molecular mechanisms research Cancer Research 6 works
- 10 Cancer Immunotherapy and Biomarkers Oncology 5 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Eastern Hepatobiliary Surgery Hospital's research output changed?
Output in 2018–2022 was 10% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Shanghai
- Shanghai Jiao Tong University
- Tongji University
- Fudan University
- Shanghai University
- East China Normal University
- East China University of Science and Technology
- Donghua University
- University of Shanghai for Science and Technology
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.